[Principal entity of hypertension version of CKD guide].
Kimura
Genjiro
G
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002908:Chronic Disease; D003131:Combined Modality Therapy; D004232:Diuretics / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000209:etiology* / Q000628:therapy*; D007674:Kidney Diseases / Q000209:etiology* / Q000628:therapy*; D008019:Life Style; D017410:Practice Guidelines as Topic; D011507:Proteinuria; D012307:Risk Factors
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004232:Diuretics